← SynDRA
SIGUAZODAN
SynDRA canonical compound SYN0024675 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PDE3A |
|---|
| Mechanism of action | Phosphodiesterase inhibitor |
|---|
| Indication | heart failure therapy |
|---|
| Disease area | Cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
Drug classes
- Phosphodiesterase Inhibitors
- Vasodilator Agents
Cross-references
Synonyms
- SK&F-94836
- SKF-94836
- 5E4UI00UQJ
- DTXCID8025202
- siguazodanum
- RefChem:182823
- NCGC00015947-02
- CAS-115344-47-3
- Siguazodan [INN:BAN]
- SR-01000075284
- UNII-5E4UI00UQJ
- SkF94836
- SIGUAZODAN [INN]
- Lopac0_000997
- BSPBio_001354
- KBioGR_000074
- KBioSS_000074
- SCHEMBL149133
- orb1309096
- SCHEMBL1024118
- SCHEMBL1024119
- SCHEMBL4459608
- SCHEMBL5170622
- SCHEMBL6558367
- SCHEMBL12648714
- SCHEMBL18522869
- CHEBI:91791
- KBio2_000074
- KBio2_002642
- KBio2_005210
- KBio3_000147
- KBio3_000148
- NUHPODZZKHQQET-UHFFFAOYSA-N
- Bio2_000074
- Bio2_000554
- GLXC-26081
- HMS1361D16
- HMS1791D16
Look up SIGUAZODAN in the interactive SynDRA portal →